Evidence map›Paper›PMID 42119907›Full record

ArticleBrain, behavior, and immunity2026

A novel soil-derived Mycolicibacterium decreases anxiety-like defensive behavioral responses in association with decreases in biomarkers of neuroinflammation and hippocampal microglial priming in adult male rats.

Haoting Zhang, Brandon M Marquart, Evan M Holbrook, Caelan T O Wright, Cristian A Zambrano, Matthew J Gebert, Lamya'a M Dawud, Nathan D Andersen, Lyanna R Kessler, Saydie A Sago and 9 more

Abstract read
In one paragraph

Article in Brain, behavior, and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Haoting ZhangDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: haoting.zhang@colorado.edu.
Brandon M MarquartDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: brandonmarquart@gmail.com.
Evan M HolbrookDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: evanholb@mit.edu.
Caelan T O WrightDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: ctwright@wisc.edu.
Cristian A ZambranoDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: cristian.zambrano@colorado.edu.
Matthew J GebertDepartment of Ecology and Evolutionary Biology, University of Colorado Boulder, Boulder, CO 80309, USA; Cooperative Institute for Research in Environmental Sciences, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: matt.gebert@colorado.edu.
Lamya'a M DawudDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: lamyaa.dawud@colorado.edu.
Nathan D AndersenDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: nathan.d.anderson@colorado.edu.
Lyanna R KesslerDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: lyanna.kessler@colorado.edu.
Saydie A SagoDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: saydie.sago@colorado.edu.
Echo Y ColeDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: echo.cole@colorado.edu.
Gabriel W Costanza-ChavezDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: gabriel.costanzachavez@colorado.edu.
Michael V BarattaDepartment of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: michael.baratta@colorado.edu.
Matthew G FrankDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: matt.frank@colorado.edu.
Andrew S MacDonaldInstitute of Immunology and Infection Research, University of Edinburgh, Edinburgh EH9 3JT, United Kingdom. Electronic address: andrew.macdonald@ed.ac.uk.
Christopher E StamperDepartment of Physical Medicine and Rehabilitation and Center for Neuroscience, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Military and Veteran Microbiome: Consortium for Research and Education (MVM-CoRE), Aurora, CO 80045, USA; Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA; Center for Microbial Exploration, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: christopher.stamper@colorado.edu.
Adam D BohrDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: adam.bohr@colorado.edu.
Noah FiererDepartment of Ecology and Evolutionary Biology, University of Colorado Boulder, Boulder, CO 80309, USA; Cooperative Institute for Research in Environmental Sciences, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: noah.fierer@colorado.edu.
Christopher A LowryDepartment of Integrative Physiology, University of Colorado Boulder, Boulder, CO 80309, USA; Department of Physical Medicine and Rehabilitation and Center for Neuroscience, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Military and Veteran Microbiome: Consortium for Research and Education (MVM-CoRE), Aurora, CO 80045, USA; Center for Neuroscience, University of Colorado Boulder, Boulder, CO 80309, USA; Center for Microbial Exploration, University of Colorado Boulder, Boulder, CO 80309, USA. Electronic address: christopher.lowry@colorado.edu.

Funding

Lead compound discovery from proprietary mycobacterial strains for treatment of PTSDR41AT011390 · NCCIH · MYCOBACTERIA THERAPEUTICS CORPORATION · PI BOHR, ADAM · 2020 to 2022
$644k
NCCIH NIH HHS R41 AT011390
6 · The paper itself

Abstract

Major traumatic life events are risk factors for stress-related neuropsychiatric disorders, often accompanied by systemic inflammation, neuroinflammation, and microglial priming. As systemic inflammation, neuroinflammation, and microglial priming are considered risk factors for developing stress-related psychiatric disorders, one novel therapeutic strategy is to identify interventions that mitigate these responses. In this study, we investigated the effects of a novel soil-derived Mycolicibacterium, Mycolicibacterium sp. strain KGA-10, on in vitro immunoregulatory potential in murine bone marrow-derived dendritic cells (BMDCs) and on biomarkers of systemic inflammation, biomarkers of hippocampal neuroinflammation and microglial priming, and anxiety-like defensive behavioral responses in adult male rats exposed to inescapable tail-shock stress (IS). In Experiments 1 and 2, BMDCs were exposed to the type strain, Mycolicibacterium vaccae ATCC 15483 (0, 10, 30, 100, 300 µg/mL; Experiment 1) or M. sp. strain KGA-10 (100 µg/mL; Experiment 2) or sterile borate-buffered saline (BBS) vehicle followed, 24 h later, by exposure to lipopolysaccharide (LPS; 250 ng/mL) or a cell culture media vehicle, then, 24 h later, assessed for Il10, Il12a, and Il12b mRNA expression. Exposure of murine BMDCs to M. vaccae ATCC 15483 or M. sp. strain KGA-10 induced an immunoregulatory phenotype, characterized by increased ratios of Il10:Il12a and Il10:Il12b mRNA expression in both naïve and lipopolysaccharide- (LPS; 250 ng/mL) challenged conditions. In Experiment 3, adult male rats received weekly injections of heat-killed M. sp. strain KGA-10 (0.1 mg/0.1 mL, s.c.) or sterile BBS vehicle over three weeks prior to IS. Anxiety-like defensive behavioral responses were assessed 24 h following IS or home cage control conditions using the juvenile social exploration (JSE) test, while biomarkers of hippocampal neuroinflammation and microglial priming were assessed using real-time reverse transcription - polymerase chain reaction (real-time RT-PCR). M. sp. strain KGA-10 treatment promoted an anti-inflammatory immunophenotype, evidenced by decreased hippocampal Il12a, and decreased biomarkers of microglial priming, Nfkbia and Nlrp3 mRNA expression among rats exposed to IS, in association with prevention of IS-induced increases in anxiety-like defensive responses in the JSE test. These findings suggest that M. sp. strain KGA-10 is a promising candidate for a novel intervention for promotion of stress resilience and prevention of stress-related psychiatric disorders.

Indexed as

AnxietyMicrogliaNeuroinflammatory DiseasesAnimalsBehavior, AnimalBiomarkersDendritic CellsHippocampusInflammationMaleMiceMycobacteriaceaeRatsRats, Sprague-DawleyStress, PsychologicalBiomarkersAnxietyBMDCBone marrow-derived dendritic cellsImmunoregulationInterleukin 10Juvenile social explorationMycolicibacteriumMycolicibacterium sp. strain KGA-10NeuroinflammationStress resilience

Identifiers

PMID42119907
PMCPMC13356705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.